Welcome to our dedicated page for Genasys SEC filings (Ticker: GNSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Genasys Inc. filings document financial results, governance actions and capital-structure disclosures for a Nasdaq-listed Protective Communications company. Recent Form 8-K reports cover results of operations, financial condition, debt repayment commentary, officer appointments, director elections, audit committee leadership and executive compensation arrangements.
The company's proxy materials and annual-meeting reports disclose board elections, auditor ratification, advisory executive-compensation votes and common-stock voting mechanics. Compensation-related filings include cash bonus metrics, restricted stock units under the 2025 Equity Incentive Plan and performance-based award terms, while exchange-act disclosures identify GNSS common stock as registered on The Nasdaq Stock Market.
Genasys Inc. returned to profitability on sharply higher revenue in its March 31, 2026 quarter. Revenue for the quarter rose to $15,505, up from $6,932 a year earlier, driven largely by hardware sales. Net income was $723, compared with a net loss of $6,139 in the prior-year quarter, and basic EPS improved to $0.02 from a loss of $0.14 per share. For the first six months, revenue reached $32,570, versus $13,872 a year ago, with operating income of $930 instead of a double-digit million loss. Cash, cash equivalents and restricted cash declined to $1,516 as of March 31, 2026, while notes payable at fair value were $14,610. One customer accounted for 66% of quarterly revenue, much of it tied to the Puerto Rico Early Warning System project, underscoring both momentum and customer concentration.
Genasys Inc. reported a strong fiscal second quarter 2026, returning to profitability and amending its debt. Revenue rose to $15.5 million, up 123.7% from $6.9 million a year earlier, with gross margin improving to 63.3% from 37.7%.
GAAP operating income reached $1.3 million, and GAAP net income was $0.7 million, or $0.02 per share, versus a prior-year loss of $6.1 million. Adjusted EBITDA improved to $2.5 million from a loss of $5.1 million. Management highlighted a roughly $58 million backlog and expects record fiscal 2026 revenue, gross margins above 50%, and full-year net income profitability.
The company ended March 31, 2026 with $1.0 million in cash, cash equivalents, and marketable securities and notes payable at fair value of $14.6 million. On May 12, 2026, Genasys extended the maturity of its term loan from May 13, 2026 to July 13, 2026 for a fee equal to 1.0% of the outstanding principal, aligning repayment with expected Puerto Rico Early Warning System project receipts.
Genasys Inc. director Lawrence F. Hagenbuch received an equity grant of 48,498 restricted stock units (RSUs), each representing one share of Genasys common stock. The RSUs were granted as part of the company’s standard compensation for non-employee directors and carry no cash exercise price.
The RSUs vest on the earlier of the company’s 2027 annual shareholder meeting or a change of control. After this grant, Hagenbuch holds 48,498 shares or share-settled units directly, aligning his compensation further with shareholder equity performance.
Genasys Inc. director Lawrence F. Hagenbuch has filed a Form 3, which is the initial statement of his beneficial ownership as a company insider. The provided information lists his role as a director but does not show any specific share holdings or report any transactions.
Genasys Inc. has appointed Larry Hagenbuch to its Board of Directors and named him Chair of the Audit Committee. He will serve until the next annual stockholder meeting and brings more than two decades of financial, operational, and restructuring experience.
Hagenbuch is an operating partner at Crossplane Capital and previously led interim management and turnaround engagements at Huron Consulting, following leadership roles at GE, GE Capital, and other firms. He has chaired or served on audit committees at several public companies, adding deep audit and governance expertise.
As part of his election, he received restricted stock units on the same terms as other non-employee directors and will be compensated under existing director practices. A press release announcing his appointment is furnished as an exhibit, and the company reiterates its focus on Protective Communications solutions deployed worldwide.
Dodd William H reported acquisition or exercise transactions in this Form 4 filing.
Genasys Inc. director William H. Dodd received an equity award of 47,620 shares of common stock in the form of restricted stock units. The grant was a compensation-related award at no cash purchase price. Following this award, he holds 176,783 shares of common stock directly.
The RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control event. Each unit represents a contingent right to receive one share of Genasys common stock, settled solely in shares rather than cash.
Fugate William Craig reported acquisition or exercise transactions in this Form 4 filing.
Genasys Inc. director William Craig Fugate received a grant of 47,620 restricted stock units (RSUs) of common stock as equity compensation, with no cash purchase price. The RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control event. Each RSU represents a contingent right to one share of Genasys common stock, to be settled solely in shares. Following this award, Fugate directly holds 115,821 shares of the company’s common stock.
Malhotra R. Rimmy reported acquisition or exercise transactions in this Form 4 filing.
Genasys Inc. director R. Rimmy Malhotra reported receiving an award of 47,620 restricted stock units (RSUs) of common stock. These RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control, and each RSU represents one share settled solely in stock, with no cash purchase price.
After this grant, Malhotra holds 196,285 shares directly. The filing also lists indirect holdings of 1,628,495 Genasys shares owned by Nicoya Fund, LLC and 300 shares owned by Nicoya Genasys‑SPV LLC, entities managed through Nicoya Capital, LLC.
Genasys Inc. director Susan Lee Schmeiser reported receiving a grant of 47,620 shares of common stock in the form of restricted stock units at no cash cost. These RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control event. Each RSU converts into one share of common stock, deliverable only in shares. Following this grant, her reported direct holdings total 193,256 shares of Genasys common stock.
Genasys Inc. reported the results of its 2026 Annual Meeting of Stockholders. There were 45,212,311 common shares outstanding and eligible to vote as of January 21, 2026, and 25,083,917 shares were represented in person or by proxy at the March 17, 2026 meeting.
All five director nominees were elected to one-year terms. Support for four nominees ranged from about 13.1 million to 13.9 million votes, while Susan Lee Schmeiser received 11,326,368 votes for and 4,044,163 withheld. Each director election had 9,713,386 broker non-votes.
Stockholders also ratified the appointment of Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending September 30, 2026, with 21,419,235 votes for, 2,005,498 against and 1,659,184 abstentions. On an advisory, non-binding basis, executive compensation was approved with 8,844,760 votes for, 5,107,733 against, 1,418,038 abstentions and 9,713,386 broker non-votes.